bucladesine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
415 362-74-3

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • bucladesine
  • Dibutyryl cAMP
  • dbcAMP
  • Cyclic AMP dibutyrate
  • bucladesine sodium
  • bucladesine sodium salt
A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed)
  • Molecular weight: 469.39
  • Formula: C18H24N5O8P
  • CLOGP: 0.74
  • LIPINSKI: 1
  • HAC: 13
  • HDO: 2
  • TPSA: 163.99
  • ALOGS: -2.46
  • ROTB: 8

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

Pharmaceutical products:

None

bucladesine